<DOC>
	<DOCNO>NCT02836639</DOCNO>
	<brief_summary>Phase II study safety efficacy BEB ( Bendamustine , Etoposide , Busulfan ) condition regimen ASCT non-Hodgkin 's lymphoma</brief_summary>
	<brief_title>BEB Conditioning Regimen Autologous Stem-cell Transplantation ( ASCT ) Non-Hodgkin 's Lymphoma</brief_title>
	<detailed_description />
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Lymphoma , Non-Hodgkin</mesh_term>
	<mesh_term>Etoposide</mesh_term>
	<mesh_term>Etoposide phosphate</mesh_term>
	<mesh_term>Busulfan</mesh_term>
	<mesh_term>Bendamustine Hydrochloride</mesh_term>
	<criteria>1 . Patients histologically diagnose nonHodgkin 's lymphoma 2 . 16 ≤ Age ≤ 65 year 3 . Adequate cardiac function cardiac ejection fraction great 50 % echocardiogram multiple gate acquisition scan ( MUGA ) 4 . Adequate kidney function serum creatinine &lt; 2.0 mg/dL 5 . Adequate liver function /serum bilirubin low 2 time normal upper limit , Aspartate aminotransferase ( AST ) / Alanine aminotransaminase ( ALT ) low 3 time normal upper limit . In case DLBCL liver invasion ; serum bilirubin low 5 time normal upper limit , AST/ALT low 5 time normal upper limit . 6 . Adequate bone marrow function absolute neutrophil count ≥ 1,500/µL ; platelet ≥ 75,000/µL ; hemoglobin ≥ 9.0 g/dL 7 . Patients voluntarily give inform consent perform test part routine care patient 8 . Candidate ASCT 1 . Positive serology HIV , hepatitis C virus ( HCV ) If hepatitis B virus ( HBV ) patient administrate prophylactic antiviral agent . It would eligible follow judgment investigator 2 . Pregnant breastfeeding . Females childbearing potential agree undergo pregnancy test repeat use effective birth control include clinical trial . 3 . Patients serious uncontrolled medical condition ; 1 ) Abnormalities cardiac function clinically significant heart disease congestive heart failure , arrhythmia , unstable angina treatment within 6 month acute myocardial infarction ; 2 ) Previous history serious neurological psychiatric disease ; 3 ) Acute , severe active infection require immediate treatment ( Virus , Bacteria , Fungal infection ) ; 4 ) chronic obstructive pulmonary disease require oral steroid therapy Forced expiratory volume 1 sec ( FEV1 ) &lt; 0.8 L less test pulmonary function rest ; 5 ) If disease deem inappropriate target present clinical trial follow Investigator 's judgment ; 6 ) Congenital acquire bleed disorder 4 . Patients receive investigational systemic therapy ( Hormone , Immune , chemotherapy ) 5 . Allergic investigational drug 6 . Patients difficulty understand informed consent form patient give consent 7 . Serum bilirubin upper 2 time normal upper limit 8 . Major surgery procedure within 30 day prior start investigational treatment 9 . Patients vaccinate yellow fever</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>